Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20201903Phase 2Completed
A Phase 2 trial of Reduning Granules in influenza, sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Sep 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20201903.